# Belatacept Conversion in Proteinuric Kidney Transplant Recipients

> **NCT02327403** · PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 15 (actual)

## Conditions studied

- Proteinuria

## Interventions

- **DRUG:** Belatacept

## Key facts

- **NCT ID:** NCT02327403
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2020-09
- **Final completion:** 2020-10-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02327403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02327403, "Belatacept Conversion in Proteinuric Kidney Transplant Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02327403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*